RECRUITING · INTERVENTIONAL · TREATMENT study · Liver Cancer (Locally Advanced or Metastatic) · Phase 1 · Enrollment 150 · Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Official title: An Open, Multicenter, Phase I Clinical Study on the Safety, Efficacy, and Pharmacokinetics of SH009 Injection in Patients With Advanced Solid Tumors.
Summary: Evaluate the efficacy and safety of SH009 injection therapy for patients with advanced solid tumors
Conditions: Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma, Breast Cancer (Locally Advanced or Metastatic), Esophageal Cancer, Gastric Cancer (GC), Solid Tumor Malignancies
Study type: INTERVENTIONAL
Primary purpose: TREATMENT
Phases: PHASE1
Enrollment: 150 (ESTIMATED)
Status: RECRUITING
Completion: 2028-12-30 (ESTIMATED)